Metabolism of 4'-Chlorodiazepam and Diclazepam in Rat Liver Microsomes

被引：0
作者：
Li L. [1 ,2 ]
Zhao J.-B. [2 ]
Yan H. [2 ]
Deng H.-X. [2 ]
Fan X.-Y. [2 ]
Liu W.-H. [1 ]
Xiang P. [2 ]
机构：
[1] School of Pharmacy, Yantai University, Yantai
[2] Shanghai Forensic Service Platform, Shanghai Key Laboratory of Forensic Medicine, Institute of Forensic Science, Ministry of Justice, PRC, Shanghai
来源：
Journal of Chinese Mass Spectrometry Society | 2022年 / 43卷 / 01期
关键词：
4'-chlorodiazepam; Diclazepam; Liver microsomes; Metabolic pathway;
D O I：
10.7538/zpxb.2020.0134
中图分类号：
学科分类号：
摘要：
To investigate the metabolic profiles of 4'-chlorodiazepam and diclazepam in vivo, the liver microsomal metabolism model was established. Firstly, the target substances were incubated in the water bath pot at 37 ℃ for about 4 h. Then the incubation buffer was terminated by ice acetonitrile. After that 10 μL of the supernatant was taken for analysing. The Agilent Eclipse plus C18 column (12.5 mm×2.1 mm×5 μm) was used and the 20 mmol/L ammonium acetate-0.1% formic acid-5% acetonitrile (A) and acetonitrile (B) were served as the gradient elution. The metabolites and metabolic pathways were identified and clarified by liquid chromatography coupled with quadrupole Exactive Orbitrap mass spectrometry (LC-Q-Exactive MS) in the full scan-ddMS2 ion mode. The results showed that 4'-chlorodiazepam produced 5 phase Ⅰ and 2 phase Ⅱ metabolites in Wistar liver microsomes, and diclazepam produced 6 phase Ⅰ and 1 phase Ⅱ metabolites in Wistar liver microsomes. The differences of the metabolites might result from the substitution position of chlorine atom. And the main metabolic pathways of 4'-chlorodiazepam and diclazepam included demethylation, mono-hydroxylation, di-hydroxylation, O-glucuronidation in this work. On the basis of experimental results, phase Ⅰ metabolites M2 (demethylation), M3 (mono-hydroxylation), M4 (demethylation and mono-hydroxylation) of 4'-chlorodiazepam and M2' (demethylation), M3' (mono-hydroxylation), M4' (demethylation and mono-hydroxylation) of diclazepam were proposed to be potential poisoning markers due to the high concentration level. Moreover, the metabolites and metabolic pathways of di-hydroxylation were the first reported. This study preliminarily clarified the metabolic pathways and main metabolites of 4'-chlorodiazepam and diclazepam in Wistar liver microsomes. It provided a theoretical basis for the pharmacokinetic and forensic scientific research of 4'-chlorodiazepam and diclazepam, which offered great value for the detection of related cases in laboratory. © 2022, Editorial Board of Journal of Chinese Mass Spectrometry Society. All right reserved.
引用
收藏
页码：34 / 43
页数：9
相关论文
共 15 条
  • [1] CORNETT E M, NOVITCH M B, BRUNK A J, DAVIDSON K S, MENARD B L, URMAN R D, KAYE A D., New benzodiazepines for sedation, Best Practice & Research Clinical Anaesthesiology, 32, 2, pp. 149-164, (2018)
  • [2] MOOSMANN B, HUTTER M, HUPPERTZ L M, BUCHWALD A, FERLAINO S, AUWARTER V., Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine, Forensic Toxicology, 31, 2, pp. 263-271, (2013)
  • [3] HUPPERTZ L M, BISEL P, WESTPHAL F, FRANZ F, AUWARTER V, MOOSMANN B., Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites, Forensic Toxicology, 33, 2, pp. 388-395, (2015)
  • [4] WATANABE S, VIKINGSSON S, ASTRAND A, AUWARTER V, GREEN H, KRONSTRAND R., Metabolism of the benzodiazepines norflurazepam, flurazepam, fludiazepam and cinolazepam by human hepatocytes using high-resolution mass spectrometry and distinguishing their intake in authentic urine samples, Forensic Toxicology, 38, 1, pp. 79-94, (2019)
  • [5] MOOSMANN B, BISEL P, FRANZ F, HUPPERTZ L M, AUWARTER V., Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines-an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam, J Mass Spectrom, 51, 11, pp. 1080-1089, (2016)
  • [6] WANG Conghui, XU Jianzhong, GU Cuihong, HUANG Xin, LIU Yao, WANG Youmei, FENG Yu, Detection of abuse drugs in human hair Ⅲ. tetrahydrocannabinol, Journal of Chinese Mass Spectrometry Society, 18, 3, pp. 7-12, (1997)
  • [7] SHEN Min, SHEN Baohua, XIANG Ping, The application of GC/MS/MS to screening for drugs of abused in hair, Journal of Chinese Mass Spectrometry Society, 23, 1, pp. 11-20, (2002)
  • [8] YAN Xiaojun, LIU Litao, GAO Mi, YIN Jianying, Detection of designer benzodiazepine diclazepam by GC/MS, Chinese Journal of Forensic Medicine, 33, 6, pp. 637-638, (2018)
  • [9] MENG L, ZHU B, ZHENG K., Ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the determination of 4 designer benzodiazepines in urine samples by gas chromatography-triple quadrupole mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 1, pp. 9-15, (2017)
  • [10] XIANG Ping, SHEN Min, SHEN Baohua, MA Dong, ZHUO Xianyi, Simultaneous screening for 59 drugs of abuse in biological samples by LC-MS/MS-MRM, Journal of Chinese Mass Spectrometry Society, 27, 4, pp. 237-241, (2006)
12